Benjamin F. Edwards & Company’s Vanguard Health Care ETF VHT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $609K | Buy |
2,291
+13
| +0.6% | +$3.41K | 0.01% | 646 |
|
|
2024
Q1 | $616K | Hold |
2,278
| – | – | 0.01% | 615 |
|
|
2023
Q4 | $571K | Buy |
2,278
+120
| +6% | +$28.4K | 0.01% | 614 |
|
|
2023
Q3 | $507K | Hold |
2,158
| – | – | 0.02% | 513 |
|
|
2023
Q2 | $528K | Hold |
2,158
| – | – | 0.02% | 496 |
|
|
2023
Q1 | $515K | Hold |
2,158
| – | – | 0.02% | 473 |
|
|
2022
Q4 | $535K | Hold |
2,158
| – | – | 0.02% | 449 |
|
|
2022
Q3 | $483K | Hold |
2,158
| – | – | 0.02% | 441 |
|
|
2022
Q2 | $508K | Hold |
2,158
| – | – | 0.02% | 448 |
|
|
2022
Q1 | $549K | Hold |
2,158
| – | – | 0.02% | 447 |
|
|
2021
Q4 | $575K | Buy |
2,158
+390
| +22% | +$99.5K | 0.03% | 443 |
|
|
2021
Q3 | $437K | Hold |
1,768
| – | – | 0.02% | 477 |
|
|
2021
Q2 | $437K | Hold |
1,768
| – | – | 0.02% | 472 |
|
|
2021
Q1 | $404K | Sell |
1,768
-62
| -3% | -$14.2K | 0.02% | 504 |
|
|
2020
Q4 | $409K | Buy |
1,830
+62
| +4% | +$13.3K | 0.02% | 482 |
|
|
2020
Q3 | $361K | Hold |
1,768
| – | – | 0.02% | 466 |
|
|
2020
Q2 | $341K | Hold |
1,768
| – | – | 0.02% | 454 |
|
|
2020
Q1 | $294K | Sell |
1,768
-95
| -5% | -$17.4K | 0.03% | 438 |
|
|
2019
Q4 | $357K | Hold |
1,863
| – | – | 0.03% | 459 |
|
|
2019
Q3 | $312K | Buy |
1,863
+1,700
| +1,043% | +$291K | 0.02% | 463 |
|
|
2019
Q2 | $28K | Hold |
163
| – | – | ﹤0.01% | 1090 |
|
|
2019
Q1 | $28K | Hold |
163
| – | – | ﹤0.01% | 1036 |
|
|
2018
Q4 | $26K | Sell |
163
-341
| -68% | -$57.8K | ﹤0.01% | 1029 |
|
|
2018
Q3 | $91K | Buy |
504
+436
| +641% | +$75K | 0.01% | 703 |
|
|
2018
Q2 | $11K | Buy |
68
+10
| +17% | +$1.57K | ﹤0.01% | 1254 |
|
|
2018
Q1 | $9K | Buy |
58
+18
| +45% | +$2.87K | ﹤0.01% | 1295 |
|
|
2017
Q4 | $6K | Buy |
40
+20
| +100% | +$3.07K | ﹤0.01% | 1330 |
|
|
2017
Q3 | $3K | Buy |
+20
| New | +$2.98K | ﹤0.01% | 1414 |
|
|
2016
Q1 | – | Sell |
-157
| Closed | -$21K | – | 1202 |
|
|
2015
Q4 | $21K | Sell |
157
-28
| -15% | -$3.65K | ﹤0.01% | 684 |
|
|
2015
Q3 | $23K | Sell |
185
-12
| -6% | -$1.65K | 0.01% | 687 |
|
|
2015
Q2 | $28K | Sell |
197
-2
| -1% | -$276 | 0.01% | 710 |
|
|
2015
Q1 | $27K | Sell |
199
-252
| -56% | -$33.2K | 0.01% | 694 |
|
|
2014
Q4 | $57K | Sell |
451
-6
| -1% | -$737 | 0.01% | 493 |
|
|
2014
Q3 | $53K | Buy |
457
+11
| +2% | +$1.26K | 0.01% | 500 |
|
|
2014
Q2 | $50K | Buy |
446
+45
| +11% | +$4.81K | 0.01% | 474 |
|
|
2014
Q1 | $43K | Buy |
401
+307
| +327% | +$32.5K | 0.01% | 467 |
|
|
2013
Q4 | $10K | Buy |
94
+76
| +422% | +$7.45K | ﹤0.01% | 661 |
|
|
2013
Q3 | $2K | Hold |
18
| – | – | ﹤0.01% | 787 |
|
|
2013
Q2 | $2K | Buy |
+18
| New | +$1.55K | ﹤0.01% | 743 |
|
Other funds holding VHT
PCH
HIIFS
EHC
BCMIO
Benjamin F. Edwards & Company's VHT Position: Q2 2024 in Review
Benjamin F. Edwards & Company increased its Vanguard Health Care ETF (VHT) stake by 0.57% in Q2 2024, buying an estimated $3.41K and bringing the position to 2,291 shares worth $609K. The position accounts for 0.01% of the portfolio, ranked #646.
Benjamin F. Edwards & Company first reported a position in VHT in Q2 2013 and has held it in 39 quarters since. The position peaked at $616K in Q1 2024. 997 funds tracked by Wall St. Rank hold VHT as of Q2 2024.
- Benjamin F. Edwards & Company held 2,291 shares of Vanguard Health Care ETF worth $609K as of Q2 2024.
- Benjamin F. Edwards & Company bought 13 Vanguard Health Care ETF shares in Q2 2024, an estimated $3.41K.
- Vanguard Health Care ETF made up 0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #646 holding.
- Benjamin F. Edwards & Company first reported a position in Vanguard Health Care ETF in Q2 2013 and has held it in 39 quarters since.
- Benjamin F. Edwards & Company's Vanguard Health Care ETF position peaked at $616K in Q1 2024.
- 997 funds tracked by Wall St. Rank held Vanguard Health Care ETF as of Q2 2024.
Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.